There are at least 113 cannabinoids known to occur in cannabis.
Many of these cannabinoids have never been fully characterized (their chemical makeup has not yet been determined), and many others are found only in trace amounts, or only in specific plant strains.
Cannabis is a wonder plant. Growing wild throughout the world for thousands of years, humans have used it to create textiles and ropes that become stronger when wet; as well as a host of medicines and other products including paper, paint, rope, fuel oils and more.
In recent decades it has gained much notoriety for its recreational and wellness uses, especially the non-psychoactive cannabinoid, CBD (Cannabidiol).
Most of these cannabinoids that are said to be not fully characterized are what many are currently referring to as the new cannabinoids. Two of the new cannabinoids that you need to know more about are CBC and CBN.
The future of hemp biomass
Hemp biomass refers to the waste that gets left by hemp cultivator after they extract their CBD from hemp flowers. Put simply, it is the hemp plant matter other than the flowers, which includes, the seeds, leaves and stalks.
If you have ever heard of hemp seed oil, then it is one of the practical examples of where hemp biomass (hemp seeds) can be used.
Hemp biomass certainly holds a bright future, especially now that hemp seed oil is trending for supplementation uses.
In the foreseeable future also, hemp biomass will also continue getting used to create bio fuel. After pressing hemp seed oil, there is the obtaining of biodiesel that can get used to power automotive. Lastly, when hemp stalks get fermented, they can be used for manufacturing hemp methanol and ethanol.
The future of CBN
CBN is a non-psychoactive cannabinoid present in cannabis. It was considered to be an inert cannabinoid until it was shown that CBN does have some activity at the CB1 receptor (like psychoactive cannabinoid) and may even serve as a precursor for psychoactive cannabinoid synthesis (Bouaboula et al., 2008). However, it works more like a CB2 receptor antagonist and has shown analgesic effects that are like psychoactive cannabinoid.
CBN works synergistically with psychoactive cannabinoid to produce anti-inflammatory effects, although it is less potent than psychoactive cannabinoid alone. CBN also seems to reduce adverse reactions such as nausea and vomiting associated with cancer therapies.
The future of CBN is not so certain, however. More research is needed to determine if there are medicinal uses for CBN. GVB Biopharma is an excellent option if you are looking for a reliable white label manufacturer and high-quality products.
Why is CBC the next up and coming cannabinoid?
CBC was once simply considered a by-product of cannabis’s psychoactive cannabinoid production, but research is now showing that it may be the other way around.
This means that CBC could be considered the more “natural” cannabinoid (or the first cannabinoid produced in nature) and may have medical uses. Some research has also shown that CBC and psychoactive cannabinoid have an antagonistic relationship, meaning that if CBC is present in an organism can reduce the effects of psychoactive cannabinoid.